Home | Welcome to Contract Pharma   
Last Updated Sunday, April 19 2015

Print

Search Results for 'Financial Report: Johnson'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 20, 2015
Pharmaceutical sales up 15% for the year Read More »
Published October 14, 2014
Pharmaceutical sales up 18% in the quarter, new products drive growth Read More »
Published July 16, 2013
Revenues up 9% in the quarter Read More »
Published April 17, 2012
1Q Revenues: $16.1 billion (flat) 1Q Earnings: $3.9 billion (+12%) Comments: Pharma sales were $6.3 billion, up 1%, with a slight negative impact from currency rates. Consumer sales dropped 2% to $3.6 billion, as the company continues to struggle w… Read More »
Published October 18, 2011
Pharmaceutical sales up 9% Read More »
Published January 26, 2010
Worldwide Pharmaceutical sales were $22.5 billion for the year (-8%), while Worldwide Medical Devices and Diagnostics sales were $23.6 billion for year (+2%). Read More »
Published October 16, 2007
Johnson & Johnson   3Q Revenues: $15 billion (+13%) 3Q Earnings: $2.5 billion (-8%) YTD Revenues: $45.1 billion (+14%) YTD Earnings: $8.2 billion (-8%) Comments: Worldwide pharmaceutical sales were $6.1 billion in the quarter,… Read More »
Published November 18, 2014
Aims to identify early-stage opportunities at leading U.S. academic research institutions Read More »
Newsmakers: RX-360
By Gil Y. Roth, Contract Pharma
Published June 5, 2013
An Rx-360 panel conversation Read More »
By Andreas Scherer, Ph.D.
Published March 21, 2012
Holy Grail or Buying Time? Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On